Abstract
In the post-genome era, designing and conducting novel experiments have become increasingly common for modern researchers. However, the major challenge faced by researchers is surprisingly not the complexity in designing new experiments or obtaining the data generated from the experiments, but instead it is the huge amount of data to be processed and analyzed in the quest to produce meaningful information and knowledge. Gene regulatory network (GRN) inference from gene expression data is one of the common examples of such challenge. Over the years, GRN inference has witnessed a number of transitions, and an increasing amount of new computational and statistical-based methods have been applied to automate the procedure. One of the widely used approaches for GRN inference is the dynamic Bayesian network (DBN). In this review paper, we first discuss the evolution of molecular biology research from reductionism to holism. This is followed by a brief insight on various computational and statistical methods used in GRN inference before focusing on reviewing the current development and applications of DBN-based methods.
Keywords: Dynamic bayesian network, gene regulatory networks, network inference, time-series gene expression data.
Current Bioinformatics
Title:Current Development and Review of Dynamic Bayesian Network-Based Methods for Inferring Gene Regulatory Networks from Gene Expression Data
Volume: 9 Issue: 5
Author(s): Lian En Chai, Mohd Saberi Mohamad, Safaai Deris, Chuii Khim Chong, Yee Wen Choon and Sigeru Omatu
Affiliation:
Keywords: Dynamic bayesian network, gene regulatory networks, network inference, time-series gene expression data.
Abstract: In the post-genome era, designing and conducting novel experiments have become increasingly common for modern researchers. However, the major challenge faced by researchers is surprisingly not the complexity in designing new experiments or obtaining the data generated from the experiments, but instead it is the huge amount of data to be processed and analyzed in the quest to produce meaningful information and knowledge. Gene regulatory network (GRN) inference from gene expression data is one of the common examples of such challenge. Over the years, GRN inference has witnessed a number of transitions, and an increasing amount of new computational and statistical-based methods have been applied to automate the procedure. One of the widely used approaches for GRN inference is the dynamic Bayesian network (DBN). In this review paper, we first discuss the evolution of molecular biology research from reductionism to holism. This is followed by a brief insight on various computational and statistical methods used in GRN inference before focusing on reviewing the current development and applications of DBN-based methods.
Export Options
About this article
Cite this article as:
Chai En Lian, Mohamad Saberi Mohd, Deris Safaai, Chong Khim Chuii, Choon Wen Yee and Omatu Sigeru, Current Development and Review of Dynamic Bayesian Network-Based Methods for Inferring Gene Regulatory Networks from Gene Expression Data, Current Bioinformatics 2014; 9 (5) . https://dx.doi.org/10.2174/1574893609666140421210333
DOI https://dx.doi.org/10.2174/1574893609666140421210333 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hedgehog Target Genes: Mechanisms of Carcinogenesis Induced by Aberrant Hedgehog Signaling Activation
Current Molecular Medicine CDC25A and B Dual-Specificity Phosphatase Inhibitors: Potential Agents for Cancer Therapy
Current Medicinal Chemistry Mucin-based Targeted Pancreatic Cancer Therapy
Current Pharmaceutical Design The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Bio Distribution
Current Drug Metabolism Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells
Current Cancer Drug Targets Radiolabeled Peptides and Proteins in Cancer Therapy
Protein & Peptide Letters Cancer Stem Cells – Are Surface Markers Alone Sufficient?
Current Stem Cell Research & Therapy Targeting Kruppel-Like Factor 5 (KLF5) for Cancer Therapy
Current Topics in Medicinal Chemistry Circular RNAs and Glioma: Small Molecule with Big Actions
Current Molecular Medicine Chitosan Derivatives with Antimicrobial, Antitumour and Antioxidant Activities - a Review
Current Pharmaceutical Design Prevention and Treatment of Bone Metastases
Current Pharmaceutical Design Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells
Anti-Cancer Agents in Medicinal Chemistry Choline Kinase: An Important Target for Cancer
Current Medicinal Chemistry Synthesis and Stereochemistry-Activity Relationship of Chiral Thiourea Derivatives as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)
Current Signal Transduction Therapy The “Big Five” Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein
Current Medicinal Chemistry Targeted Protein Degradation: An Emerging Therapeutic Strategy in Cancer
Anti-Cancer Agents in Medicinal Chemistry Synthetic 2-Methoxyestradiol Derivatives: Structure-Activity Relationships
Current Medicinal Chemistry Targeting the Ubiquitin E1 as a Novel Anti-Cancer Strategy
Current Pharmaceutical Design Osteopontin; as a Target Molecule for the Treatment of Inflammatory Diseases
Current Drug Targets